Pfizer (PFE) Other Non-Current Liabilities (2009 - 2026)
Pfizer (PFE) recorded Other Non-Current Liabilities of $14.78 billion in Q2 2026, up 6.1% from $13.93 billion a year earlier and up 4.1% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer reported Other Non-Current Liabilities of $14.73 billion, up 4.1% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $14.15 billion in FY2024 (-14.4%), $16.54 billion in FY2023 (+25.5%), $13.18 billion in FY2022 (+16.3%) and $11.33 billion in FY2021 (-2.0%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities since Q3 2024.
- On a year-over-year basis, Other Non-Current Liabilities has increased for three consecutive quarters, with an average decline of 5.1% over the last seven quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 25.5% in Q4 2023, against a decline of 14.4% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.2 billion (Q1 2026), $14.73 billion (Q4 2025) and $13.61 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 135.25 Bn | 107.26 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 18.60 Bn |
| Mar 29, 2026 | 17.91 Bn |
| Dec 31, 2025 | 18.32 Bn |
| Sep 28, 2025 | 17.01 Bn |
| Jun 29, 2025 | 17.24 Bn |
| Mar 30, 2025 | 19.02 Bn |
| Dec 31, 2024 | 20.26 Bn |
| Sep 29, 2024 | 21.47 Bn |
| Jun 30, 2024 | 22.63 Bn |
| Mar 31, 2024 | 23.73 Bn |
| Dec 31, 2023 | 25.07 Bn |
| Oct 1, 2023 | 22.34 Bn |
| Jul 2, 2023 | 21.46 Bn |
| Apr 2, 2023 | 22.87 Bn |
| Dec 31, 2022 | 22.99 Bn |
| Oct 2, 2022 | 21.94 Bn |
| Jul 3, 2022 | 22.30 Bn |
| Apr 3, 2022 | 22.08 Bn |
| Dec 31, 2021 | 21.07 Bn |
| Oct 3, 2021 | 20.54 Bn |
API Access
Pfizer Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();